Anzeige
Mehr »
Montag, 03.11.2025 - Börsentäglich über 12.000 News
Der menschliche Genius hinter den Maschinen: Telescope Innovations und der Aufstieg der autonomen Wissenschaft
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 853815 | ISIN: US0718131099 | Ticker-Symbol: BTL
Tradegate
03.11.25 | 17:35
15,800 Euro
-1,32 % -0,212
Branche
Gesundheitswesen
Aktienmarkt
S&P 500
1-Jahres-Chart
BAXTER INTERNATIONAL INC Chart 1 Jahr
5-Tage-Chart
BAXTER INTERNATIONAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
15,70215,75818:42
15,70215,75818:39
PR Newswire
494 Leser
Artikel bewerten:
(2)

Baxter International Inc.: Surgeons Convene at Vienna Symposium to Experience Baxter's HEMOPATCH Sealing Hemostat

DEERFIELD, Ill., Aug. 18, 2025 /PRNewswire/ --

General Surgeon, Professor Selman Uranüs

Trusted for Over a Decade.
For over a decade, Hemopatch sealing hemostat has been a trusted companion in surgeries worldwide, providing critical support and precision under pressure, while evolving with the healthcare landscape.

A New Milestone: HEMOPATCH Sealing Hemostat, Now in Room Temperature
At a symposium in Vienna, Austria, Baxter unveiled the new Hemopatch sealing hemostat, a room-temperature collagen pad designed for hemostasis and sealing in both open and minimally invasive surgical procedures (MIS).1 This event marked the culmination of a decade-long collaboration between experts and developers. Hemopatch sealing hemostat is a more thoughtful solution shaped directly by feedback from those who use it daily. During the event, expert speakers shared how their insights and experiences drove the development of the new Hemopatch sealing hemostat, addressing an audience of surgeons from diverse specialties.

General Surgeon Professor Selman Uranüs, an early adopter who attended the symposium, said:
"I first used Hemopatch sealing hemostat for experimental testing. Since then, I've used it daily for its unique sealing properties, especially in laparoscopic surgery. Eliminating the need for refrigeration and extending shelf life are crucial improvements, ensuring it's available in the OR when it matters most."

A Reaffirmation of Trust and Partnership
The symposium reaffirmed our shared commitment to continuous innovation. The new Hemopatch sealing hemostat is designed for direct accessibility in the OR, reflecting our dedication to advancing surgical care with practical tools. Its new configuration is the result of close collaboration with surgeons, ensuring it meets real clinical needs.

We look forward to sharing more as the global roll out continues.

For more information on Hemopatch sealing hemostat,
Visit: https://advancedsurgery.baxter.eu/hemopatch

Reference

1.Hemopatch sealing hemostat Instructions for Use.

Manufacturer:

Baxter Healthcare SA

Thurgauerstrasse 130 Glattbrugg,

ZÜRICH, 8152 Switzerland

Class of Device: III

CE0123

This content is intended solely for healthcare professionals and should not be interpreted as medical advice. Please consult with a qualified healthcare provider for any health concerns.

Hemopatch sealing hemostat is approved for use only in selected countries. For specific information on the availability and regulatory status of Hemopatch sealing hemostat room temperature in your country, we recommend contacting your local Baxter Healthcare sales representative.

Baxter and Hemopatch are trademarks of Baxter International Inc. or its subsidiaries.

GBU-AS21-250025 (v1.0) 08/2025

HEMOPATCH Sealing Hemostat Indications and Important Risk Information

Baxter International Inc.

Photo - https://mma.prnewswire.com/media/2747929/Baxter_International_At_Vienna_Symposium.jpg
Photo - https://mma.prnewswire.com/media/2747930/Baxter_International_Hemopatch.jpg
Logo - https://mma.prnewswire.com/media/2687591/Baxter_International_Inc_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/surgeons-convene-at-vienna-symposium-to-experience-baxters-hemopatch-sealing-hemostat-302529527.html

© 2025 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.